HPV-ASSOCIATED CANCERS

Clinical trials for HPV-ASSOCIATED CANCERS explained in plain language.

Never miss a new study

Get alerted when new HPV-ASSOCIATED CANCERS trials appear

Sign up with your email to follow new studies for HPV-ASSOCIATED CANCERS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Not yet recruiting 2 Completed 1 Terminated 1

New drug tested for tough HPV cancers that Won't quit

Disease control Completed

This early-stage trial tested a new drug called TGN-S11 in people with HPV-related cancers that had returned, resisted treatment, or spread. The main goal was to find the highest safe dose. The study involved 28 participants whose cancers had progressed despite standard treatment…

Matched conditions: HPV-ASSOCIATED CANCERS

Phase: PHASE1 • Sponsor: Toragen, Inc. • Aim: Disease control

Last updated Mar 17, 2026 13:09 UTC

HPV-ASSOCIATED CANCERS

Get alerted when new HPV-ASSOCIATED CANCERS trials appear

New drug tested for tough HPV cancers that Won't quit